Yiqun Li, Ying Wang, De Zeng, Yuan Wu, Xiwen Bi, Huafeng Kang, Feng Wang, Li Li, Yongmei Yin, Qiao Li, Xiaodong Gu, Huihui Li, Binghe Xu. "Effectiveness and safety of disitamab vedotin (RC48) in pretreated HER2-positive advanced breast cancer: A real-world experience in China.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e13006